Thymosin Alpha1 Clinical Trials

2 actively recruiting trials

Also known as: Thymalfasin, Tα1

Pipeline

Phase 3: 1

Top Sponsors

Yousheng Mao1
Fudan University1

Indications

Cancer2
Stage III Colorectal Cancer1
Stage II Colorectal Cancer1
Lung Cancer1
Non Small Cell Lung Cancer1

Other2 trials

Immuno-effect of Tα1 for Stage I NSCLC

N/A

Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.